Elettaria cardamomum
Green cardamom, a spice sold as seed powder or extract. Black cardamom (Amomum) is a different plant and is not filed here.
Description on record
Findings
9 findings9 shown
- HDL cholesterolMoved: raisesEvidence: ModeratePaper: PMID 308715142019
- Who
- overweight or obese adults (30-60 years) with non-alcoholic fatty liver disease by ultrasonography; both arms given lifestyle advice (5% weight-loss diet and moderate aerobic activity)
- Dose studied
- 3 g/day, two 0.5 g capsules per meal with food, for 3 months
In other words, GC in comparison with placebo significantly elevated irisin, HDL-c, and QUICKI and reduced FBI, HOMA-IR, TG, and LDL-c (P < 0.05).”
Quoted verbatim from Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.RCTPermalink - HOMA-IRMoved: lowersEvidence: Moderatereplicated ×1Paper: PMID 308715142019
- Who
- overweight or obese adults (30-60 years) with non-alcoholic fatty liver disease by ultrasonography; both arms given lifestyle advice (5% weight-loss diet and moderate aerobic activity)
- Dose studied
- 3 g/day, two 0.5 g capsules per meal with food, for 3 months
In other words, GC in comparison with placebo significantly elevated irisin, HDL-c, and QUICKI and reduced FBI, HOMA-IR, TG, and LDL-c (P < 0.05).”
Quoted verbatim from Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.RCTPermalink - TriglyceridesMoved: lowersEvidence: ModeratePaper: PMID 308715142019
- Who
- overweight or obese adults (30-60 years) with non-alcoholic fatty liver disease by ultrasonography; both arms given lifestyle advice (5% weight-loss diet and moderate aerobic activity)
- Dose studied
- 3 g/day, two 0.5 g capsules per meal with food, for 3 months
In other words, GC in comparison with placebo significantly elevated irisin, HDL-c, and QUICKI and reduced FBI, HOMA-IR, TG, and LDL-c (P < 0.05).”
Quoted verbatim from Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.RCTPermalink - Diastolic blood pressureMoved: lowersEffect, as reportedMD−0.91[−1.19 to −0.62]Evidence: Very limitedPaper: PMID 361812642023
- Who
- patients with metabolic syndrome and related disorders; random-effects pooling of randomized clinical trials
- Dose studied
- not reported
The findings indicated that green cardamom significantly decreased diastolic blood pressure (WMD: -0.91 mmHg, 95%CI; -1.19, -0.62), high-sensitivity C-reactive protein (WMD: -1.21 mg/L, 95%CI; -2.18, -0.24), interleukin 6 levels (WMD: -2.41 ng/L, 95%CI; -4.35, -0.47).”
Quoted verbatim from The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink - Interleukin-6 concentrationMoved: lowersEffect, as reportedMD−2.41[−4.35 to −0.47]Evidence: Very limitedPaper: PMID 361812642023
- Who
- patients with metabolic syndrome and related disorders; random-effects pooling of randomized clinical trials
- Dose studied
- not reported
The findings indicated that green cardamom significantly decreased diastolic blood pressure (WMD: -0.91 mmHg, 95%CI; -1.19, -0.62), high-sensitivity C-reactive protein (WMD: -1.21 mg/L, 95%CI; -2.18, -0.24), interleukin 6 levels (WMD: -2.41 ng/L, 95%CI; -4.35, -0.47).”
Quoted verbatim from The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink - Glycated haemoglobin (HbA1c)Moved: lowersEvidence: Very limitedPaper: PMID 307015542019
- Who
- overweight or obese adults with type 2 diabetes mellitus
- Dose studied
- 3 g/day green cardamom for 10 weeks
Compared to the control group, a significant decrease in serum HbA1C (-0.4%), insulin (-2.8 µIU dL-1 ), HOMA-IR (-1.7) and TG (-39.9 mg dL-1 ), and an increase in SIRT1 (2.3 ng mL-1 ) was observed in cardamom group.”
Quoted verbatim from Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.RCT · 2 monthsPermalink - Systolic blood pressureMoved: no difference foundEvidence: Very limitedPaper: PMID 361812642023
- Who
- patients with metabolic syndrome and related disorders; random-effects pooling of randomized clinical trials
- Dose studied
- not reported
However, cardamom supplementation did not significantly affect systolic blood pressure.”
Quoted verbatim from The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink - HOMA-IRMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 307015542019
- Who
- overweight or obese adults with type 2 diabetes mellitus
- Dose studied
- 3 g/day green cardamom for 10 weeks
Compared to the control group, a significant decrease in serum HbA1C (-0.4%), insulin (-2.8 µIU dL-1 ), HOMA-IR (-1.7) and TG (-39.9 mg dL-1 ), and an increase in SIRT1 (2.3 ng mL-1 ) was observed in cardamom group.”
Quoted verbatim from Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.RCT · 2 monthsPermalink - C-reactive protein concentrationMoved: lowersEffect, as reportedMD−1.21[−2.18 to −0.24]Evidence: Very limitedPaper: PMID 361812642023
- Who
- patients with metabolic syndrome and related disorders; random-effects pooling of randomized clinical trials
- Dose studied
- not reported
The findings indicated that green cardamom significantly decreased diastolic blood pressure (WMD: -0.91 mmHg, 95%CI; -1.19, -0.62), high-sensitivity C-reactive protein (WMD: -1.21 mg/L, 95%CI; -2.18, -0.24), interleukin 6 levels (WMD: -2.41 ng/L, 95%CI; -4.35, -0.47).”
Quoted verbatim from The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.meta-analysisPermalink
No row matches these filters.
No dose is advised.
Papers about it
Found by a search for it7
Show the papersHide the papers
Comparison of the effect of ice sucking containing peppermint (Mentha piperita L.) with cardamom (Elettaria cardamomum) extract on nausea, vomiting, and drug request after laparoscopic cholecystectomy.
Explore (New York, N.Y.)2025PMID 40967081Via: a search for it
The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.
Phytotherapy research2023PMID 36181264Via: a search for it
Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial.
Eating and weight disorders2022PMID 34057705Via: a search for it
Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
Journal of the science of food and agriculture2019PMID 30701554Via: a search for it
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
BMC complementary and alternative medicine2019PMID 30871514Via: a search for it
The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study protocol for a randomized placebo-controlled clinical trial.
BMC complementary and alternative medicine2018PMID 29343256Via: a search for it
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Trials2017PMID 28592311Via: a search for it
Newest
Comparison of the effect of ice sucking containing peppermint (Mentha piperita L.) with cardamom (Elettaria cardamomum) extract on nausea, vomiting, and drug request after laparoscopic cholecystectomy.
Explore (New York, N.Y.)2025PMID 40967081Found by a search for it
The effect of green cardamom on blood pressure and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials.
Phytotherapy research2023PMID 36181264Found by a search for it
Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial.
Eating and weight disorders2022PMID 34057705Found by a search for it
Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
Journal of the science of food and agriculture2019PMID 30701554Found by a search for it
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
BMC complementary and alternative medicine2019PMID 30871514Found by a search for it
Seven kinds
- 01PathwaysReactions grouped under one name
- 02ProcessesWhat proteins are annotated as doing
- 03AnatomyTissues, by what is expressed there
- 04Cell typesCells, by what is expressed there
- 05OrganismsSpecies a compound is prepared from
- 06MaterialsSubstances that are not one molecule
- 07AssessmentsRegulatory determinations, transcribed